Ignore these warning signs at your own peril Read More

This week, I take a look at some of the highest-yielding Dividend Aristocrats. These all-weather income generators belong in any portfolio. Read More

When individual stocks and sectors trade independently of each other, it's a sign the bear is waning. Read More

Target has gained 145% since we recommended it two years ago. Here's an investment tactic that could have done even better. Read More

We don't recommend buying stock in Teva Pharmaceutical, but there's a way to profit from Teva even if its share price doesn’t move. Read More

There are valuable lessons from stocks that don't initially behave as we expected. In some cases, patience and guile can be rewarding. Read More

As the drug chain grapples with a slowing economy and online competition, should you dump WBA stock or is it a contrarian buy? Read More

E-commerce giant Amazon dominates the retail jungle, but do competitors and bearish economic indicators threaten the stock? Read More

Can struggling industrial colossus General Electric turn itself around or is the company's dividend doomed? We look at the declining fortunes of a former "buy-and-hold forever" stock. Read More